RNA Therapeutics and Delivery Strategies: Innovations, Challenges, and Clinical Translation
TL;DR
The different forms of RNA-based treat-ments, such as messenger RNAs, small interfering RNAs, and circular RNAs, are discussed in this paper along with their significance in gene regulation and the treatment of disease.
Abstract
A rapidly growing class of medications called RNA therapeutics could transform indi-vidualized treatment and target "undruggable" areas. The different forms of RNA-based treat-ments, such as messenger RNAs (mRNAs), small interfering RNAs (siRNAs), and circular RNAs (circRNAs), are discussed in this paper along with their significance in gene regulation and the treatment of disease. Stability and efficient distribution to target cells are major challeng-es for RNA molecules. Hydrogels, dendrimers, and lipid nanoparticles are being developed to improve RNA therapy pharmacokinetics and cellular absorption. More accurate and efficient therapies are also being made possible by breakthroughs in self-amplifying RNA (saRNA) tech-nology and the application of artificial intelligence in RNA delivery design. The review also dis-cusses RNA modifications and synthetic biology in pharmaceutical design. Although good data from preclinical and clinical trials demonstrate the potential of RNA-based therapeutics, further research is necessary to tackle translational difficulties and improve delivery mechanisms for therapeutic usage. RNA treatments may revolutionize medical research by treating cancer and genetic defects.